Skip to main content
. 2018 Nov 16;54(7):1049–1057. doi: 10.1038/s41409-018-0382-3

Table 2.

Infectious complications after haplo-PBSCT-Cord

N (%)
CMV viremia 12 (37.5%)
CMV disease 1 (3.1%)
EB infection viremia 13 (40.6%)
PTLD EB related 1 (3.4%)
Hemorrhagic cystitis BK virus-related 5 (15.6%)
Pneumonia
  Virus 1 (3.1%)
  Fungal 3 (9.4%)
  Bacteria 1 (3.1%)
Pneumocystis carinii pneumonia 1 (3.1%)

CMV cytomegalovirus, PTLD posttransplant lymphoproliferative disorder